|
|
| Insulin Assay | ||
| Order Code: INSL
Order Form: A-1a Miscellaneous Request or IPR Req |
Chemistry 6240 RCP 356-3527 |
|
Specimen |
Plasma | ||
Collection Medium: |
| ||
Alternate Collection Media: |
Call laboratory for additional acceptable specimen collection containers. | ||
Minimum: |
5 mls whole blood from light green top tubes or three 0.6 microtubes from a fasting patient. | ||
Delivery Instructions: |
Deliver to laboratory immediately after collection. | ||
Testing Schedule: |
Batch analysis performed on Tuesdays and Fridays. Sample must be received by 0800 for same day service. For additional services, contact Clinical Pathology Resident on-call at pager #3404. | ||
Reference Range: |
2.6 - 24.9 micro U/mL (fasting) | ||
Comments: |
This insulin assay does NOT measure the insulin analogs lispro (Humalog), aspart (NovoLog), and glargine (Lantus). Please contact the laboratory if an assay with crossreactivity to these insulin analogs is required. This assay will allow measurement of free insulin by removal of anti-insulin antibodies with PEG. The laboratory will report results both with PEG precipitation (free insulin) and without PEG precipitation (total insulin). A glucose will be automatically done on each specimen at no additional charge. | ||
Test Limitations: |
The assay is unaffected by icterus (bilirubin is less than 90 mg/dl),
lipemia (Intralipid is less than 1800 mg/dl) and biotin is less than 60
ng/ml (criterion: recovery within plus or minus 10% of initial value).
Hemolysis interferes.
In patients receiving therapy with high biotin doses (i.e. is greater
than 5 mg/day) no sample should be taken until at least 8 hours after
the last biotin administration.
Samples from patients treated with bovine or porcine insulin sometimes
contain anti-insulin antibodies which can affect the test results.(1-2)
As with all tests containing monoclonal mouse antibodies, erroneous
findings may be obtained from samples taken from patients who have been
treated with monoclonal mouse antibodies or have received them for
diagnostic purposes. Elecsys Insulin contains additives which minimize
these effects. In rare cases, interference due to extremely high titers
of antibodies to streptavidin can occur.
For diagnostic purposes, Insulin findings should always be assessed in
conjunction with the patient's medical history, clinical examination
and other findings.
(1) Fiedler, H. Basiswissen Labordiagnostik: Diabetes mellitus und
metabolisches Syndrom. Roche Diagnostics Brochure 1999;14,67 Cat
No. 1951769.
(2) Tietz NW. Clinical Guide To Laboratory Tests. 3rd ed. Philadelphia,
Pa: WB Saunders Co, 1995:366-367. | ||
Methodology: |
Electrochemiluminescence Immunoassay | ||
CPT Code: |
83525 | ||
See Additional Information: Fasting Specimen Requirements Specimens Requiring Immediate Delivery |
Updated: 12/06/2007
Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.